CAS
GILD icon

Coppell Advisory Solutions’s Gilead Sciences GILD Stock Holding History

Coppell Advisory Solutions’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,475
Closed -$2.4M – 161
2025
Q4 		$2.4M Sell
19,475
-568
-3% -$69K 0.24% 88
2025
Q3 		$2.26M Sell
20,043
-101
-0.5% -$11.5K 0.24% 89
2025
Q2 		$2.23M Sell
20,144
-3,179
-14% -$338K 0.26% 73
2025
Q1 		$2.43M Sell
23,323
-11,719
-33% -$1.21M 0.34% 62
2024
Q4 		$3.22M Sell
35,042
-2,556
-7% -$230K 0.45% 40
2024
Q3 		$3.14M Sell
37,598
-373
-1% -$28.5K 0.46% 38
2024
Q2 		$2.61M Buy
+37,971
New +$2.53M 0.43% 48
2023
Q4 		$2.2M Buy
27,142
+9,049
+50% +$704K 0.44% 50
2023
Q3 		$1.55M Sell
18,093
-4,218
-19% -$324K 0.53% 48
2023
Q2 		$1.7M Buy
22,311
+3,177
+17% +$253K 0.48% 46
2023
Q1 		$1.56M Buy
19,134
+1,041
+6% +$86.2K 0.51% 46
2022
Q4 		$1.55M Buy
+18,093
New +$1.43M 0.53% 48
2020
Q4 		$548K Buy
+9,402
New +$567K 0.28% 95

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Coppell Advisory Solutions's GILD Position: Q1 2026 in Review

Coppell Advisory Solutions sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 19,475 shares — an estimated $2.4M sold.

Coppell Advisory Solutions first reported a position in GILD in Q4 2020 and held it in 13 quarters. The position peaked at $3.22M in Q4 2024. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Coppell Advisory Solutions reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • Coppell Advisory Solutions sold 19,475 Gilead Sciences shares in Q1 2026, an estimated $2.4M.
  • Coppell Advisory Solutions first reported a position in Gilead Sciences in Q4 2020 and held it in 13 quarters.
  • Coppell Advisory Solutions's Gilead Sciences position peaked at $3.22M in Q4 2024.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Coppell Advisory Solutions's 13F filing for Q1 2026, filed 15 May 2026.